Investors finally received updates from Adamis (ADMP) and Sandoz about the planned launch of SYMJEPI. The Adamis press release was short, but provided some insight on the company’s recent actions to support the launch. According to the press release,
“Manufacture of commercial batches has been completed and Adamis will begin shipping to Sandoz distribution centers during December to ensure the appropriate supply for launch.”
Sandoz Inc., a Novartis division (NVS), sent out their own press release highlighting expected launch time and price. Sandoz announced a planned U.S. launch of SYMJEPI